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ABSTRACT 
Dense inorganic nanoparticles have recently been identified as promising radiosensitizers. In addition to dose 
enhancement through increased attenuation of ionizing radiation relative to biological tissue, scintillating nanoparticles 
can transfer energy to coupled photosensitizers to amplify production of reactive oxygen species, as well as provide UV-
visible emission for optical imaging. Lanthanum fluoride is a transparent material that is easily prepared as nanocrystals, 
and which can provide radioluminescence at a number of wavelengths through simple substitution of lanthanum ions 
with other luminescent lanthanides. We have prepared lanthanum fluoride nanoparticles doped with cerium, terbium, or 
both, that have good spectral overlap with chlorin e6 or Rose Bengal photosensitizer molecules. We have also developed 
a strategy for stable conjugation of the photosensitizers to the nanoparticle surface, allowing for high energy transfer 
efficiencies on a per molecule basis. Additionally, we have succeeded in making our conjugates colloidally stable under 
physiological conditions. Here we present our latest results, using nanoparticles and nanoparticle-photosensitizer 
conjugates to demonstrate radiation dose enhancement in B16 melanoma cells. The effects of nanoparticle treatment 
prior to 250 kVp x-ray irradiation were investigated through clonogenic survival assays and cell cycle analysis. Using a 
custom apparatus, we have also observed scintillation of the nanoparticles and conjugates under the same conditions that 
the cell samples are irradiated.  
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1. INTRODUCTION 
Nanoparticles with high atomic numbers, for example gold [1] and bismuth [2], are promising low-toxicity agents that 
can amplify the effective dose of ionizing radiation in a cell in which they are present.  If successfully targeted to cancer 
cells, such nanoparticles could reduce the needed dose of therapeutic radiation or make a standard dose more effective 
against radiation-resistant cancers. This is especially relevant to lower-energy radiation sources such as brachytherapy, 
since the photoelectric effect is the primary mode of action at these energies [3] [4].  
Although a large number of theoretical, in vitro and in vivo studies have confirmed this mechanism, there are still no 
clinical trials of Au-nanoparticle enhanced radiation therapy[5] [6] [7]. The primary obstacle is the large fraction of 
metal required in the cell for a substantial dose enhancement, with resulting difficulties in targeting and concerns about 
toxicity. Depending upon their shape and size, nanoparticles distribute to the spleen, liver, and/or kidneys, and may cause 
damage to these organs as well as potentially to the heart [8] [9] [10, 11]. 
Photodynamic therapy (PDT) is an alternative to radiation therapy that results in fewer side effects, better healing, and 
less damage to surrounding normal tissue. The mechanism of action of PDT is generation of singlet oxygen by a 
photosensitizing dye that has been allowed to accumulate in inflamed or malignant tissue.  An external light source 
excites the dye once optimal accumulation has occurred (usually several days after injection). Because of the short radius 
of action of singlet oxygen, only localized cell damage takes place. Unfortunately, PDT is limited to cancers that are 
unpigmented, superficial, and accessible by a light source [12-14]. If the photosensitizer could be excited through deeper, 
pigmented tissue, the advantages of PDT could be extended to deeper lesions.  
Invited Paper
Colloidal Nanoparticles for Biomedical Applications XI, edited by Wolfgang J. Parak, Marek Osinski, Xing-Jie Liang
Proc. of SPIE Vol. 9722, 97220V · © 2016 SPIE · CCC code: 0277-786X/16/$18 · doi: 10.1117/12.2213374
Proc. of SPIE Vol. 9722  97220V-1
Downloaded From: http://proceedings.spiedigitallibrary.org/ on 10/13/2016 Terms of Use: http://spiedigitallibrary.org/ss/termsofuse.aspx
  
If ionizing radiation could be used to excite a photosensitizer, the problem of penetration of the excitation light would be 
eliminated. While some dyes excite directly with x-rays or other therapeutic radiation, most do not. The most general 
approach to the problem is therefore to conjugate a dye used in photodynamic therapy to a nanoparticle that emits light 
under radioexcitation (scintillates) [15]. As with other types of energy transfer, the absorption spectrum of the 
photosensitizer dye must overlap with the emission spectrum of the nanoparticle. A few studies on this approach have 
been published, but the problem is complicated by the lack of biologically stable nanoscintillators [16, 17]. Nanoparticle 
aggregation must be minimized and the ligand chosen so that it is not displaced by inorganic salts or organic molecules 
present in the solutions used. In addition, the ligand has to contain a functional group that permits covalent attachment of 
photosensitizers to the nanoparticle. Previous work in our group has shown that the bisphosphonate alendronate satisfies 
most of these requirements [18], but nanoparticles coated with alendronate alone require conditions too acidic for 
biological applications (pH < 4).   
Here we report alendronate-PEG capped lanthanum fluoride (LaF3) nanoparticles doped with cerium (Ce3+) and/or 
terbium (Tb3+). The particles are stable in cell culture media. The emission spectrum of Ce3+ overlaps with the blue Soret 
band of most photosensitizers. Tb3+ has a strong emission peak at 542 nm, which overlaps with the absorption spectrum 
of the photosensitizer rose bengal (RB). We show energy transfer to the photosensitizers by steady-state and time-
resolved emission spectroscopy, and demonstrate that the particles emit under x-ray excitation using therapeutic energies 
and dose rates. 
2.   MATERIALS AND METHODS 
2.1 Particle synthesis    
Lanthanum (III) nitrate hexahydrate (99.999%), citric acid (ACS, ≥99.5%), 6-bromohexanoic acid (97%), 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC) and ammonium fluoride (99.99%) were purchased from Sigma-Aldrich and 
used without further modification. Ammonium hydroxide (ACS) was purchased from ACP Chemicals Inc. Chlorin e6 
(Ce6) was purchased from Frontier Scientific. Alendronate sodium trihydrate (97%), cerium (III) nitrate hydrate 
(REacton, 99.998%), terbium (III) nitrate hydrate (REO, 99.9%) and N-hydroxysuccinimide (NHS, >98%) were 
purchased from Alfa Aesar. mPEG-succinimidyl valerate (mPEG2000-SVA, MW 2000) was purchased from Laysan Bio 
Inc. 
Citrate stabilized, doped lanthanum fluoride core/shell nanoparticles were synthesized using a slightly modified version 
of a previously published hydrothermal method. Briefly, citric acid (10.4 mmol) was dissolved in 35 mL of milli-Q 
water, and the pH adjusted to 4.5 using 28% NH4OH. This solution was heated to 75 °C while stirring at 600 rpm. The 
lanthanide precursor solution (total of 1.33 mmol in 2 mL methanol) and NH4F (8.38 mmol in 2 mL water) were then 
added consecutively to the citric acid solution at 4 mL/h. This solution was stirred at 75 °C for 2 hours, followed by 
dropwise addition of lanthanum nitrate (1.33 mmol in 2 mL methanol) at 4 mL/h to form a nominally undoped LaF3 
shell. After stirring for another 2 h, the mixture was cooled to room temperature and the nanoparticles were precipitated 
using an equal volume of ethanol followed by centrifugation at 4000 rpm for 10 min. This was repeated twice. Finally, 
the particles were re-suspended in distilled water and filtered through a two stage Millex 0.45/1.0 μm PVDF/APFB 
syringe filter to produce a final stock solution of 20-30 mg/mL. 
2.2 Time-Resolved Fluorescence Measurements 
Fluorescence lifetimes were measured using the time-correlated single photon counting (TCSPC) technique with the 
apparatus previously described1. Briefly, the output of a Coherent RegA 9050 Ti/sapphire regenerative amplifier (800 
nm, 80 fs pulses at 250 kHz repetition rate) was coupled into an OPA (Coherent 9450) producing 504 nm pulses. The 
OPA output was used to generate a 252 nm ( 2HWHMλΔ = nm) second harmoniс in a type I BBO crystal. The harmonic 
was separated from 504 nm light by means of a calcium-fluoride prism pair. The 252 nm beam was gently focused inside 
the sample with focal spot of 0.8 mm diameter. The excitation power at the sample was varied between 7 – 170 µW. The 
photoluminescence was collected with a 3.5 cm focal length lens at 90 degrees to the excitation beam and focused by a 
10 cm focal length lens into a vertical slit of a CVI CMSP112 double spectrograph with a 1/8 m total path length in 
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negative dispersive mode with a pair of 1200 (blazed for 200 nm) or 600 (blazed for 600 nm) grooves per mm gratings 
(overall f number 3.9). The slit widths were 1.2 mm and based on a monochromator dispersion of 14 nm mm-1, provided 
5 to 10 nm resolution depending on the wavelength. A Hamamatsu RU3809 microchannel plate photomultiplier was 
mounted on the monochromator output. A Becker and Hickl SPC-630 photon counting board was used to record the 
time-resolved emission. The reference signal was provided by a portion of the amplifier output sent to a fast photodiode. 
Count rates were held at less than 1% of the laser repetition rate to avoid pulse pile up. Typical acquisition times were 10 
minutes for a single scan, but in some cases varied up to 20 minutes. Lifetimes of wavelengths higher than 400 nm were 
recorded with 420 nm cutoff filter to eliminate monochromator second order grating transmission. The full width at half-
maximum of the instrument response function (IRF) measured from scatter off a solution of dilute coffee creamer was 
less than 40 ps. IRF deconvolution, multi-exponential decay fits and intensity-weighted average lifetime calculations 
were performed using FluoFit 4.0 software (PicoQuant, Berlin). Goodness-of-fit data and residuals were used to gauge 
fit results; a χ2 between 0.9–1.5 and random distribution of residuals along the time delay axis were considered signs of 
accurate fitting. Lifetime decay contributions were weighted by fractional intensity. Negative amplitude decays 
(representing the rise times) were included in the calculation of average values, but not for fractional decay intensities. 
Multi-exponential decay fits were obtained from  
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where (t')F   is the instrument response function, maximum n was 4. 
2.3   Steady-State Fluorescence Measurements 
Steady-state fluorescence was collected using a Horiba Fluorolog-3 fluorimeter. For all measurements, the emission and 
detection slits were set to 4 nm. Integration time was 0.1 seconds, and 5 consequent scans were collected and averaged. 
All spectra were corrected for variations in excitation lamp intensity. Background scans with emission of a cell with 
water only were also collected and when necessary subtracted from sample spectra. For samples that emitted both the 
UV and visible, two scans were performed separately: one for 200 – 450 nm and another one for 460 – 900 nm with a 
490 nm cut off filter to block second order monochromator grating transmission. Fits to spectra were performed using a 
set of no more than four Gaussian functions in the Matlab Curve Fitting Toolbox with no constraints on the parameters. 
2.4 Radioluminescence Measurements 
Radioluminescence (scintillation) was measured using a custom built apparatus described elsewhere2. Briefly, a cell with 
nanoparticles was placed inside an x-ray machine  (X-RAD iR160), which was operated at 150 kVp and 20 mA using a 2 
mm Al filter. Radioluminescence was collected from the surface layer of the liquid perpendicular to X-ray direction and 
focused by a lens into an optical fiber. The fiber was coupled to a monochromator (CM110, Spectral Products) with 
overall resolution about 7 nm. The signal was detected at the monochromator output by a PMT (R928P, Hamamatsu) 
operating at 1 kV and subsequently processed by a photon counter (SR400, Stanford Research Systems). Obtained 
spectra were not corrected for monochromator and fiber transmittance and PMT sensitivity. The detector was cooled 
with dry ice; dark current was around 1-2 counts per second. Several measurements were done using the fiber and lens 
alone, an empty quartz cell, and a cell with H2O to estimate the background radioluminescence. Solutions of 
nanoparticles or conjugates were measured in quartz cuvettes (Starna) at room temperature. Samples were not 
deoxygenated. Samples containing conjugated Chlorin e6 or Rose Bengal were replaced with fresh solutions every 20 
minutes to ensure chemical stability of the sample. Concentrations of all samples we kept at 50 µg/mL or lower to avoid 
possible aggregation. The concentration of the nanoparticles was 22 mg/mL.  
2.5 Cell Culture and Toxicity Assays 
B16 murine melanoma cells were a gift of J. Teodoro, McGill Cancer Centre, and were maintained at 37 °C/5% CO2 in 
Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% 
penicillin/streptomycin. All cells were grown in T25 flasks and passaged every two days. 
The effect of varying concentrations of rose bengal conjugates on B16 cells compared to rose bengal alone was 
investigated using a sulforhodamine-B (SRB) assay. In each experiment, 5000 B16 cells were plated in a 96-well plate, 
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except for the outermost wells, which had only PBS. After 24 hours, the wells were washed with PBS and nanoparticle 
conjugates with concentrations ranging from 0 to 1000 ug/mL were added. This corresponded to rose bengal 
concentrations from 0 to 37.6 uM. There were three wells with nanoparticle conjugates, and three wells with equivalent 
concentrations of rose bengal alone. The cells were incubated with nanoparticles for 2 h, after which they were washed 
three times with PBS and fresh DMEM added. After a further 24 hours, the cells were fixed and stained with the SRB 
dye, and the absorbance measured at 510 nm using a Tecan Infinite PRO 200 spectrometer. 
 
3.   RESULTS 
3.1 Steady-state emission 
Steady-state fluorescence quenching due to conjugated photosensitizers was observed. The UV and visible emission of 
the La0.9Ce0.1F3-PEG nanoparticles and of Chlorin e6 conjugates emission spectra excited with 252 nm is shown in Fig. 
1. A control sample that had Chlorin e6 attached to Ce-free nanoparticles also was studied to ensure that the observed 
quenching was due to energy transfer and not simply the presence of the nanoparticle. 
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Fig. 1 emission spectra of La0.9Ce0.1F3-PEG-Chlorin e6 (green curves), of LaF3-PEG-Chlorin e6 (red curves, 
control) and La0.9Ce0.1F3-PEG (blue curves, free NPs) 
 
The emission of conjugated Chlorin e6 was 42% (by number of photons) more intense compared to emission of Chlorin 
e6 bound to Ce-free nanoparticles. At the same time the intensity of Ce ion emission (in the UV part of the spectrum) in 
nanoparticles that had Chlorin e6 attached was reduced by 87%. 
Similar results were observed for (Ce, Tb)-doped nanoparticles with Rose Bengal covalently attached. The UV 
and visible parts of the La0.6Ce0.2Tb0.2F3-PEG nanoparticle emission spectra are shown in Fig. 2. The UV emission of 
La0.6Ce0.2Tb0.2F3-PEG has one very wide peak centered at 330 nm, which rises from 275 nm and extends until ~450 nm. 
The visible part of the La0.6Ce0.2Tb0.2F3-PEG fluorescence has 4 distinct Tb transitions located at 488 nm, 543 nm, 583 
nm, and 620 nm. 
Conjugation of rose bengal to the nanoparticles led to a decrease in the absolute intensity of Ce and Tb 
emission, suggesting energy transfer. In the UV range, Ce emission was quenched by 90%; in the visible range, Tb 
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emission was quenched by about 99.6% based upon the integrated number of photons detected. The emission intensity of 
rose bengal did not significantly change upon conjugation. 
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Fig. 2 Emission spectra of La0.6Ce0.2Tb0.2F3-PEG (blue curve), La0.6Ce0.2Tb0.2F3-PEG-RB (green curve) and LaF3-PEG-RB 
control (red curve). 
The UV part of the spectrum of La0.6Ce0.2Tb0.2F3-PEG was fitted with sum of Gaussians to identify distinct emission 
bands (Fig. 3). A satisfactory R2 was obtained only with the sum of 4 Gaussians. Two of these bands corresponded to 
native D -> F Ce3+ transitions: G1 and G2 with peaks at 283 nm (4.38 ±  0.01 eV) and 305 nm (4.06 ±  0.01 eV). Bands 
G3 and G4 were attributed to perturbed Ce sites. Taking into account the small size of NPs it is reasonable that emission 
from the perturbed sites dominates unperturbed Ce transitions.   
Fig. 3 UV part of La0.6Ce0.2Tb0.2F3-PEG fluorescence fitted with 4 Gaussians. 
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3.2 Time-resolved emission 
Based on the steady-state fits, TSCPC lifetime measurements were done at 4.38 eV (283 nm), 4.15 eV (298 nm) and 4.35 
eV (370 nm). The lifetimes of rose bengal were measured at 568 nm, which is close to the rose bengal emission peak and 
falls between the sharp Tb emission peaks. The lifetimes of the Ce emission upon conjugation to rose bengal were 
consistently shorter compared to nanoparticles without rose bengal. The emission lifetime of free rose bengal was a 0.09 
ns monoexponential decay. Conjugated rose rengal dye had several components of the decay with lifetimes of 0.05, 0.12, 
1.54 and 4.68 ns. Figures 4 and 5 show lifetimes of Ce ions in La0.6Ce0.2Tb0.2F3-PEG nanoparticles and in 
La0.6Ce0.2Tb0.2F3-PEG-RB conjugates showing a pronounced change of the 298 and 370 nm emission lifetimes after 
attaching rose bengal.  
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Fig. 4. Fluorescence lifetimes of La0.6Ce0.2Tb0.2F3-PEG 
nanoparticles at different wavelengths: 283, 298 and 379 
nm. 
Fig. 5. Fluorescence lifetimes of La0.6Ce0.2Tb0.2F3-PEG-
RB conjugates at the same as on fig. 4 (283, 298 and 379 
nm) wavelengths. 
 
Fig. 6 presents the 283 nm lifetimes before and after the conjugation procedure, and lifetimes of conjugated and free rose 
bengal are shown in Fig. 7. 
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Fig. 6 Fluorescence lifetimes of free and conjugated 
nanoparticles at 283 nm. 
Fig. 7 Lifetimes of conjugated and free Rose Bengal. Insert shows 
lifetimes in the region from 0 to 2.5 ns. 
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3.3 Radioluminescence 
The radioluminescence spectrum of La0.6Ce0.2Tb0.2F3-PEG did not significantly differ from photoexcited fluorescence, as 
seen in Fig. 8. We also attempted to detect scintillation of La0.6Ce0.2Tb0.2F3-PEG-RB conjugates, but the signal did not 
substantially differ from background due to very strong quenching (Fig. 9). 
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Fig 8 scintillation of La0.6Ce0.2Tb0.2F3-PEG at 22.2 
mg/mL concentration  
Fig. 9 La0.6Ce0.2Tb0.2F3-PEG-RB at 25 mg/mL concentration 
 
3.4 Conjugate toxicity in cells 
As initially prepared, the rose bengal-nanoparticle conjugates showed unacceptable levels of toxicity (Fig. 10 A). Only 
after ethanol wash was toxicity reduced to the level of rose bengal alone (Fig. 10 B). The effects of these particles in 
cells with radiation remain to be tested. 
 
Figure 10. Survival curves of (A) Nanoparticle-rose bengal conjugates as prepared vs. rose bengal alone. (B) After 2x 
ethanol wash. 
4. SUMMARY AND CONCLUSION 
Radioluminescence spectra of La0.6Ce0.2Tb0.2F3-PEG nanoparticles are similar to the photoexcited fluorescence. 
The photophysical results on the nanoparticle-rose bengal conjugates suggest that they should be useful for 
radiosensitization in cells. The increase of the fluorescence lifetime of conjugated rose bengal suggests energy transfer 
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between nanoparticles and the photosensitizer. The decreased fluorescence lifetime of the UV part of the emission 
spectrum of nanoparticles suggests that the excitation of rose bengal is transferred not only from Tb ions—whose 
emission spectra overlap with absorption spectrum of rose bengal—but also from Ce ions. 
Since both Ce and Tb ions contribute to energy transfer from nanoparticle to conjugated photosensitizer it would be 
interesting to evaluate how elemental and fractional compositions of nanoparticle influence radioluminescence spectra 
shape and absolute photon yield.  
Biological experiments remain to be done, and should be performed using clonogenic assays. 
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